New Insights Into Pheochromocytoma Surveillance of Young Patients With VHL Missense Mutations
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | FAGUNDES, Gustavo F. C. | |
dc.contributor.author | PETENUCI, Janaina | |
dc.contributor.author | JR, Delmar M. Lourenco | |
dc.contributor.author | TRARBACH, Ericka B. | |
dc.contributor.author | PEREIRA, Maria Adelaide A. | |
dc.contributor.author | D'EUR, Joya Emilie Correa | |
dc.contributor.author | HOFF, Ana O. | |
dc.contributor.author | LERARIO, Antonio M. | |
dc.contributor.author | ZERBINI, Maria Claudia N. | |
dc.contributor.author | SIQUEIRA, Sheila | |
dc.contributor.author | YAMAUCHI, Fernando | |
dc.contributor.author | SROUGI, Victor | |
dc.contributor.author | TANNO, Fabio Y. | |
dc.contributor.author | CHAMBO, Jose Luis | |
dc.contributor.author | LATRONICO, Ana Claudia | |
dc.contributor.author | MENDONCA, Berenice B. | |
dc.contributor.author | V, Maria Candida B. Fragoso | |
dc.contributor.author | ALMEIDA, Madson Q. | |
dc.date.accessioned | 2019-11-06T18:50:11Z | |
dc.date.available | 2019-11-06T18:50:11Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Context: Von Hippel-Lindau (VHL) disease is an autosomal dominant syndrome caused by germline mutations in the VHL gene. Guidelines recommend pheochromocytoma (PHEO) biochemical screening should start at age 5 years. Objective: Genotype-phenotype correlations in VHL, focusing on PHEO penetrance in children, were studied. Design: We retrospectively evaluated 31 individuals (median age at diagnosis was 26 years) with diagnosed VHL disease. Results: PHEO was diagnosed in six children with VHL. A large PHEO (5 cm) was detected in a 4-yearold boy with p.Gly114Ser mutation. PHEO penetrance was 55% starting at age 4 years. VHL missense mutations were identified in 11 of 22 families (50%), frameshift mutations in four (18.2%), stop codon in three (13.6%), splicing site in two (9.1%), and large gene deletion in two (9.1%). The codon 167 (n = 10) was a hotspot for VHL mutations and was significantly associated with PHEO (90% vs. 38%; P = 0.007). PHEOs and pancreatic neuroendocrine tumors (PNETs) were strongly associated with VHL missense mutations compared with other mutations (89.5% vs. 0% and 73.7% vs. 16.7%; P = 0.0001 and 0.002, respectively). In contrast, pancreatic cysts (91.7% vs. 26.3%; P = 0.0001), renal cysts (66.7% vs. 26.3%; P = 0.027), and central nervous system hemangioblastomas (91.7% vs. 47.3%; P = 0.012) were more frequent in VHL with nonmissense mutations. Conclusion: VHL missense mutations were highly associated with PHEO and PNETs. Our data support that in children with VHL harboring missense mutations, biochemical screening for PHEO should be initiated at diagnosis. | eng |
dc.description.index | PubMed | eng |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/17049-8] | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for Scientific and Technological Development (CNPq) [403256/2016-0, 302849/2015, 303002/2016-6] | |
dc.identifier.citation | JOURNAL OF THE ENDOCRINE SOCIETY, v.3, n.9, p.1682-1692, 2019 | |
dc.identifier.doi | 10.1210/js.2019-00225 | |
dc.identifier.eissn | 2472-1972 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/34094 | |
dc.language.iso | eng | |
dc.publisher | ENDOCRINE SOC | eng |
dc.relation.ispartof | Journal of the Endocrine Society | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright ENDOCRINE SOC | eng |
dc.subject | von Hippel-Lindau | eng |
dc.subject | pheochromocytoma | eng |
dc.subject | pancreatic neuroendocrine tumors | eng |
dc.subject | surveillance | eng |
dc.subject.other | von-hippel-lindau | eng |
dc.subject.other | tumor-suppressor gene | eng |
dc.subject.other | germline mutations | eng |
dc.subject.other | disease | eng |
dc.subject.other | phenotype | eng |
dc.subject.other | genotype | eng |
dc.subject.other | identification | eng |
dc.subject.other | paraganglioma | eng |
dc.subject.wos | Endocrinology & Metabolism | eng |
dc.title | New Insights Into Pheochromocytoma Surveillance of Young Patients With VHL Missense Mutations | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 14 | |
hcfmusp.contributor.author-fmusphc | GUSTAVO FREITAS CARDOSO FAGUNDES | |
hcfmusp.contributor.author-fmusphc | JANAINA PETENUCI | |
hcfmusp.contributor.author-fmusphc | DELMAR MUNIZ LOURENCO JUNIOR | |
hcfmusp.contributor.author-fmusphc | ERICKA BARBOSA TRARBACH | |
hcfmusp.contributor.author-fmusphc | MARIA ADELAIDE ALBERGARIA PEREIRA | |
hcfmusp.contributor.author-fmusphc | JOYA EMILIE DE MENEZES CORREIA | |
hcfmusp.contributor.author-fmusphc | ANA AMELIA FIALHO DE OLIVEIRA HOFF | |
hcfmusp.contributor.author-fmusphc | ANTONIO MARCONDES LERARIO | |
hcfmusp.contributor.author-fmusphc | MARIA CLAUDIA NOGUEIRA ZERBINI | |
hcfmusp.contributor.author-fmusphc | SHEILA APARECIDA COELHO SIQUEIRA | |
hcfmusp.contributor.author-fmusphc | FERNANDO IDE YAMAUCHI | |
hcfmusp.contributor.author-fmusphc | VICTOR SROUGI | |
hcfmusp.contributor.author-fmusphc | FABIO YOSHIAKI TANNO | |
hcfmusp.contributor.author-fmusphc | JOSE LUIS CHAMBO | |
hcfmusp.contributor.author-fmusphc | ANA CLAUDIA LATRONICO XAVIER | |
hcfmusp.contributor.author-fmusphc | BERENICE BILHARINHO DE MENDONCA | |
hcfmusp.contributor.author-fmusphc | MARIA CANDIDA BARISSON VILLARES FRAGOSO | |
hcfmusp.contributor.author-fmusphc | MADSON QUEIROZ DE ALMEIDA | |
hcfmusp.description.beginpage | 1682 | |
hcfmusp.description.endpage | 1692 | |
hcfmusp.description.issue | 9 | |
hcfmusp.description.volume | 3 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 31528828 | |
hcfmusp.origem.scopus | 2-s2.0-85086575380 | |
hcfmusp.origem.wos | WOS:000486639700005 | |
hcfmusp.publisher.city | WASHINGTON | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.relation.reference | Abbott MA, 2006, AM J MED GENET A, V140A, P685, DOI 10.1002/ajmg.a.31116 | eng |
hcfmusp.relation.reference | Aufforth RD, 2015, J CLIN ENDOCR METAB, V100, P4498, DOI 10.1210/jc.2015-3045 | eng |
hcfmusp.relation.reference | Blansfield JA, 2007, SURGERY, V142, P814, DOI 10.1016/j.surg.2007.09.012 | eng |
hcfmusp.relation.reference | CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109 | eng |
hcfmusp.relation.reference | Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029 | eng |
hcfmusp.relation.reference | CROSSEY PA, 1994, HUM MOL GENET, V3, P1303 | eng |
hcfmusp.relation.reference | Dahia PLM, 2014, NAT REV CANCER, V14, P108, DOI 10.1038/nrc3648 | eng |
hcfmusp.relation.reference | Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672 | eng |
hcfmusp.relation.reference | De Luca A, 2007, J MED GENET, V44, P800, DOI 10.1136/jmg.2007.053785 | eng |
hcfmusp.relation.reference | de Mestier L, 2015, ANN SURG, V262, P384, DOI 10.1097/SLA.0000000000000856 | eng |
hcfmusp.relation.reference | Erlic Z, 2010, ENDOCR-RELAT CANCER, V17, P875, DOI 10.1677/ERC-10-0037 | eng |
hcfmusp.relation.reference | Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844 | eng |
hcfmusp.relation.reference | Igarashi H, 2014, J GASTROENTEROL, V49, P511, DOI 10.1007/s00535-013-0794-1 | eng |
hcfmusp.relation.reference | Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502 | eng |
hcfmusp.relation.reference | Krauss T, 2018, ENDOCR-RELAT CANCER, V25, P783, DOI 10.1530/ERC-18-0100 | eng |
hcfmusp.relation.reference | Kruizinga RC, 2014, ENDOCR-RELAT CANCER, V21, P63, DOI 10.1530/ERC-13-0308 | eng |
hcfmusp.relation.reference | LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574 | eng |
hcfmusp.relation.reference | Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498 | eng |
hcfmusp.relation.reference | Li MQ, 2011, J CELL MOL MED, V15, P187, DOI 10.1111/j.1582-4934.2010.01238.x | eng |
hcfmusp.relation.reference | Nielsen SM, 2016, J CLIN ONCOL, V34, P2172, DOI 10.1200/JCO.2015.65.6140 | eng |
hcfmusp.relation.reference | Nordstrom-O'Brien M, 2010, HUM MUTAT, V31, P521, DOI 10.1002/humu.21219 | eng |
hcfmusp.relation.reference | Peng SH, 2017, ONCOTARGET, V8, P38456, DOI 10.18632/oncotarget.16594 | eng |
hcfmusp.relation.reference | Rednam SP, 2017, CLIN CANCER RES, V23, pE68, DOI [10.1158/1078-0432.CCR-17-0834, 10.1158/1078-0432.CCR-17-0547] | eng |
hcfmusp.relation.reference | Sovinz P, 2010, AM J MED GENET A, V152A, P1752, DOI 10.1002/ajmg.a.33407 | eng |
hcfmusp.relation.reference | Stolle C, 1998, HUM MUTAT, V12, P417, DOI 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.3.CO;2-B | eng |
hcfmusp.relation.reference | Tirosh A, 2018, JAMA ONCOL, V4, P124, DOI 10.1001/jamaoncol.2017.3428 | eng |
hcfmusp.relation.reference | Vikkath N, 2015, FAM CANCER, V14, P585, DOI 10.1007/s10689-015-9806-z | eng |
hcfmusp.scopus.lastupdate | 2024-04-12 | |
relation.isAuthorOfPublication | 963b404d-efc7-4c23-b8c6-8aec23ae863a | |
relation.isAuthorOfPublication | 4bdfe884-e4a8-4cc0-b4cc-2b885ab2bec7 | |
relation.isAuthorOfPublication | 4116c9e2-ec58-47ae-9681-7d52c81a6c24 | |
relation.isAuthorOfPublication | b21a640d-68bb-4926-984d-c83deb6f9130 | |
relation.isAuthorOfPublication | 9798b3b9-eeaf-461a-ab69-685ac4a52abf | |
relation.isAuthorOfPublication | db3f9586-e645-45d6-81a8-2c2bca763805 | |
relation.isAuthorOfPublication | 4459d441-0fc6-4861-8ab8-98e0b5e0452c | |
relation.isAuthorOfPublication | 0e586d8e-f956-4b42-9e12-e6d5558cb290 | |
relation.isAuthorOfPublication | 71cbe6cf-ec3c-4df8-bc56-ff122fd165f6 | |
relation.isAuthorOfPublication | b252a61c-8d83-482a-b0e6-549aa261f716 | |
relation.isAuthorOfPublication | 5accada2-0448-4547-a695-3880a3823efd | |
relation.isAuthorOfPublication | 7d190461-4e42-4986-b05a-330ae50fc9de | |
relation.isAuthorOfPublication | 1b95728f-0c29-4b66-acbd-a4b19c245749 | |
relation.isAuthorOfPublication | 6ff046d9-e545-49e5-a299-4ae2318a73e3 | |
relation.isAuthorOfPublication | 8ceff58e-e048-497c-9b17-0fe099ac7631 | |
relation.isAuthorOfPublication | f9dd8bf5-173e-4843-93cd-66012ee0ef1b | |
relation.isAuthorOfPublication | a481603e-cea4-445c-bdb8-12a6f5a5c200 | |
relation.isAuthorOfPublication | 9f21360e-d6ed-4f8e-a23b-45738a6f1b21 | |
relation.isAuthorOfPublication.latestForDiscovery | 963b404d-efc7-4c23-b8c6-8aec23ae863a |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_FAGUNDES_New_Insights_Into_Pheochromocytoma_Surveillance_of_Young_Patients_2019.PDF
- Tamanho:
- 517.9 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/14
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/14